DVDMDG Rozman 2010 Agenda

Breakfast – 8:00-8:55

Introduction – 8:55-9:00

9:00-9:35 - Rachel Reams - Director of Pathology, Covance Discovery Services: “Biomarkers: the Translation "Journey" from Bench to Bedside”

9:40-10:15 - John Roberts – Pharmacokinetics Scientist, Drug Metabolism and Pharmacokinetics, AstraZeneca - "Electroencephalography PK/PD as a Translational CNS Biomarker"

Break – 10:20-10:40

10:40-11:15 - Ian Blair – A. N. Richards Professor of Pharmacology, University of Pennsylvania: “Novel 15-Prostaglandin Dehydrogenase-Derived Endogenous Anti-Proliferative Lipids”

11:20-11:55 - Rachel Tyndale - Canada Research Chair in Pharmacogenetics, University of Toronto: “Genotype and biomarkers indicate genetic differences in smoking behaviours and treatment response”

Lunch – 12:00-1:30

1:30-2:05 - Don Mager - Assistant Professor, Department of Pharmaceutical Sciences, University at Buffalo, SUNY: “Pharmacokinetics and Exposure-Response Relationships of Biologics”

2:10-2:45 - Brian Kirby - Senior Graduate Student, Department of Pharmaceutics, University of Washington: “In-Vitro to In-Vivo Prediction of Complex DDIs Involving the Anti-HIV Protease Inhibitors”

Break – 2:50-3:20

3:20-4:05 - Paul Watkins – Director, The Hamner - UNC Institute for Drug Safety Sciences: “Why Good Drugs are Sometimes Bad for the Liver”

4:10-4:45 - Curtis Klaassen - University Distinguished Professor and Chair, Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center: "Regulation of Phase I and II Drug Metabolism Enzymes and Transporters"

4:50-5:15 - Wrap-up – additional questions to all speakers